Point72 Asia (Singapore) Pte. Ltd. Evolus, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $384 Billion
- Q1 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Evolus, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 2,874 shares of EOLS stock, worth $31,412. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,874Holding current value
$31,412% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding EOLS
# of Institutions
173Shares Held
47MCall Options Held
720KPut Options Held
532K-
Perceptive Advisors LLC New York, NY5.75MShares$62.9 Million1.69% of portfolio
-
Tang Capital Management LLC San Diego, CA4.15MShares$45.3 Million7.07% of portfolio
-
Black Rock Inc. New York, NY3.26MShares$35.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.04MShares$33.3 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.91MShares$31.8 Million2.62% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $613M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...